metformin has been researched along with Lymphoma, Non-Hodgkin in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 610,089 newly diagnosed type 2 diabetes patients with 2 or more times of prescription of antidiabetic drugs during 1999-2009 were enrolled from Taiwan's National Health Insurance database." | 1.51 | Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes. ( Tseng, CH, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 3 |
| Phillips, LS | 3 |
| Rohan, TE | 3 |
| Ho, GYF | 3 |
| Shadyab, AH | 3 |
| Bidulescu, A | 3 |
| Rudick, CN | 3 |
| Pan, K | 3 |
| Chen, Z | 3 |
| Luo, J | 3 |
| Ye, X | 1 |
| Zhang, G | 1 |
| Righolt, C | 1 |
| Johnston, JB | 1 |
| Banerji, V | 1 |
| Gibson, SB | 1 |
| Mahmud, SM | 1 |
| Tseng, CH | 1 |
3 other studies available for metformin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lymphoma, Non-Hodgki | 2023 |
Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lymphoma, Non-Hodgki | 2023 |
Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lymphoma, Non-Hodgki | 2023 |
Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lymphoma, Non-Hodgki | 2023 |
Metformin Is Not Associated with Incidence Risk of Non-Hodgkin Lymphomas among Diabetic Patients.
Topics: Adult; Aged; Case-Control Studies; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Incidence | 2018 |
Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.
Topics: Adult; Aged; Comorbidity; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Incidence; | 2019 |